Awadhesh Kumar Singh (Awadhesh K Singh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Journal of diabetes

Expert review of clinical pharmacology

International journal of general medicine

Diabetes, obesity & metabolism

G.D Hospital & Diabetes Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

G.D Hospital & Diabetes Institute

India

M.D (Medicine); D.M (Endocrinology), Consultant Endocrinologist :: Endocrinology

Publications

Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update. Expert review of clinical pharmacology 17 (4) (2024)
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update. Expert review of clinical pharmacology (2024)
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update. Expert review of clinical pharmacology 17 (4) (2024)
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
Anti-obesity medications: current and futureAn overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update. Expert review of clinical pharmacology (2024)
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Om Tantia, Ghanshyam Goyal, Jagat Jyoti Mukherjee, Awadhesh Kumar Singh
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update. Expert review of clinical pharmacology 17 (4) (2024)
Mahmoud Nassar, Hazem Maarouf Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Journal of diabetes (2023)
Mahmoud Nassar, Hazem Maarouf Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Journal of diabetes 15 (2) (2023)
Mahmoud Nassar, Hazem Maarouf Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Journal of diabetes 15 (2) (2023)
Mahmoud Nassar, Hazem Maarouf Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Journal of diabetes 15 (2) (2023)
Mahmoud Nassar, Hazem Maarouf Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Journal of diabetes 15 (2) (2023)
Arjun Baidya, Asish Kumar Basu, Rana Bhattacharyya, Dibakar Biswas, Kaushik Biswas, Partha Pratim Chakraborty, Purushottam Chatterjee, Subhankar Chowdhury, Ranen Dasgupta, Amritava Ghosh, Sujoy Ghosh, Debasis Giri, Soumik Goswami, Indira Maisnam, Animesh Maiti, Sunetra Mondal, Pradip Mukhopadhyay, Sarmishtha Mukhopadhyay, Satinath Mukhopadhyay, Salil Kumar Pal, Kaushik Pandit, Sayantan Ray, Bibek Roy Chowdhury, Moutusi Raychaudhuri, Pradip Raychaudhuri, Ajitesh Roy, Pranab Kumar Sahana, Debmalya Sanyal, Trinanjan Sanyal, Ravi Kant Saraogi, Dasarathi Sarkar, Nilanjan Sengupta, Awadhesh Kumar Singh, Anirban Sinha
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement. Journal of pediatric endocrinology & metabolism : JPEM (2022)
Awadhesh Kumar Singh, Ritu Singh, Kamlesh Khunti F MedSci
Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957. Diabetes care 43 (12) (2021)
Awadhesh Kumar Singh, Ritu Singh
Letter by Awadhesh Kumar Singh Regarding Article, "Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis". Journal of lipid and atherosclerosis 11 (1) (2021)
Awadhesh Kumar Singh, Ritu Singh, Partha Pratim Chakraborty
Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes. International journal of general medicine 14 (2021)
Awadhesh Kumar Singh, Ritu Singh, Anoop Misra
Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction? Journal of diabetes 13 (7) (2021)
Awadhesh Kumar Singh, Clare L Gillies, Ritu Singh, Akriti Singh, Yogini Chudasama, Briana Coles, Samuel Seidu, Francesco Zaccardi, Melanie Jane Davies, Kamlesh Khunti
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)

Awadhesh Kumar Singh.css-eqlu8i{font-size:small;padding-left:4px;} (Awadhesh K Singh)

Publication Activity (10 Years)

Top Topics

Top Venues

Awadhesh Kumar Singh (Awadhesh K Singh)